Cyclotides as a basis for drug design.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Cyclotides as a basis for drug design.
- Published In:
- Expert opinion on drug discovery, 7(3), 179-94 (2012)
- Authors:
- Craik, David J(14), Swedberg, Joakim E(2), Mylne, Joshua S, Cemazar, Masa
- Database ID:
- RPEP-01922
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01922APA
Craik, David J; Swedberg, Joakim E; Mylne, Joshua S; Cemazar, Masa. (2012). Cyclotides as a basis for drug design.. Expert opinion on drug discovery, 7(3), 179-94. https://doi.org/10.1517/17460441.2012.661554
MLA
Craik, David J, et al. "Cyclotides as a basis for drug design.." Expert opinion on drug discovery, 2012. https://doi.org/10.1517/17460441.2012.661554
RethinkPeptides
RethinkPeptides Research Database. "Cyclotides as a basis for drug design." RPEP-01922. Retrieved from https://rethinkpeptides.com/research/craik-2012-cyclotides-as-a-basis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.